Compounder Nets Warning Letter for Insanitary, cGMP Issues

By Sam | January 31, 2017

The FDA served Auro Pharmacies — a California-based compounder — with a warning letter after the agency determined the firm produced products under insanitary conditions.
Source: Drug Industry Daily

Posted in Drug Industry Daily